Trius Therapeutics, Inc. (NASDAQ:TSRX)

CAPS Rating: 3 out of 5

Recs

0
Player Avatar marsuculix (< 20) Submitted: 11/13/2012 3:48:13 AM : Outperform Start Price: $4.95 TSRX Score: -13.93

Trius Therapeutics will profit from the race for new antibiotics!

Featured Broker Partners


Advertisement